DLBCL, Nos Genetic Subtypes Clinical Trials

5 clinical trials for DLBCL, Nos Genetic Subtypes across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma — RECRUITING · PHASE1
• Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma — RECRUITING · PHASE1
• Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL — RECRUITING · PHASE2
• Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas — ACTIVE_NOT_RECRUITING · PHASE2

Refine this search